{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:40822695-5442-4ae3-a9b8-8052e35cab26", "type": "composite", "version": "1", "versioncreated": "2026-09-27T03:01:25.307327Z", "firstcreated": "2026-09-27T03:01:25.307327Z", "pubstatus": "usable", "language": "ro", "headline": "Sute de procese invocă un risc rar de pierdere a vederii la medicamentele GLP-1 pentru slăbit", "description_text": "Pacienți din SUA au dat în judecată producătorii Ozempic, Wegovy, Mounjaro și Zepbound, susținând că tratamentele le-au cauzat neuropatia optică ischemică anterioară (NAION), o afecțiune rară ce poate duce la orbire. Novo Nordisk și Eli Lilly resping acuzațiile, iar studiile observaționale arată un risc absolut foarte scăzut.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:39f70f38-fdf5-48f6-a5e1-423f6b76c390", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-09-27T03:04:58.725526Z", "firstcreated": "2026-09-27T03:01:25.307327Z", "pubstatus": "usable", "urgency": 5, "language": "ro", "headline": "Sute de procese invocă un risc rar de pierdere a vederii la medicamentele GLP-1 pentru slăbit", "byline": "Ioana Dumitrescu", "located": "Romania", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Prisma Zilei", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Prisma Zilei”. Set rel=canonical to https://prismazilei.mib.news/externe/sute-de-procese-invoca-un-risc-rar-de-pierdere-a-vederii-la-medicamentele-glp-1-pentru-slabit/ when publishing on the web.", "description_text": "Pacienți din SUA au dat în judecată producătorii Ozempic, Wegovy, Mounjaro și Zepbound, susținând că tratamentele le-au cauzat neuropatia optică ischemică anterioară (NAION), o afecțiune rară ce poate duce la orbire. Novo Nordisk și Eli Lilly resping acuzațiile, iar studiile observaționale arată un risc absolut foarte scăzut.", "altids": {"mosaic": "39f70f38-fdf5-48f6-a5e1-423f6b76c390", "story": "40822695-5442-4ae3-a9b8-8052e35cab26", "slug": "sute-de-procese-invoca-un-risc-rar-de-pierdere-a-vederii-la-medicamentele-glp-1-pentru-slabit"}, "subject": [{"name": "General news", "rel": "direct", "literal": "general", "code": "medtop:11000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/11000000"}], "place": [{"name": "Romania", "literal": "ro", "code": "RO", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:7eae7333-39e7-45a6-883e-506e951195d8", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Alertă pentru pacienții care folosesc GLP-1 să slăbească: sute de procese invocă un risc rar de pierdere a vederii", "description_text": "Sute de procese invocă un risc rar de pierdere a vederii la medicamentele GLP-1 pentru slăbit", "copyrightholder": "mediafax.ro", "copyrightnotice": "Alertă pentru pacienții care folosesc GLP-1 să slăbească: sute de procese invocă un risc rar de pierdere a vederii", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "7eae7333-39e7-45a6-883e-506e951195d8"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "RSS source", "licence_verified_at": "2026-09-27T03:04:58.751476Z", "attribution_required": true, "attribution_text": "Alertă pentru pacienții care folosesc GLP-1 să slăbească: sute de procese invocă un risc rar de pierdere a vederii", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "mediafax.ro", "source_url": "https://www.mediafax.ro/wp-content/uploads/2025/08/4226570-mediafax_foto-ovidiu_micsik-1024x683.jpg", "source_page_url": "https://www.mediafax.ro/wp-content/uploads/2025/08/4226570-mediafax_foto-ovidiu_micsik-1024x683.jpg", "our_page_url": "https://prismazilei.mib.news/externe/sute-de-procese-invoca-un-risc-rar-de-pierdere-a-vederii-la-medicamentele-glp-1-pentru-slabit/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.mediafax.ro/wp-content/uploads/2025/08/4226570-mediafax_foto-ovidiu_micsik-1024x683.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:40822695-5442-4ae3-a9b8-8052e35cab26", "slug": "sute-de-procese-invoca-un-risc-rar-de-pierdere-a-vederii-la-medicamentele-glp-1-pentru-slabit-20260927", "status": "developing", "languages": ["ro"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Prisma Zilei", "canonical_required": true, "canonical_url": "https://prismazilei.mib.news/externe/sute-de-procese-invoca-un-risc-rar-de-pierdere-a-vederii-la-medicamentele-glp-1-pentru-slabit/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_verified", "needs_review": false}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 1, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Acest material a fost realizat cu ajutorul IA sub responsabilitatea editorială a Haydamax OÜ.", "independence_check": {"status": "passed", "score": 0.132, "checked_at": "2026-09-27T03:04:58.747145Z"}, "sources": [{"url": "https://www.mediafax.ro/externe/alerta-pentru-pacientii-care-folosesc-glp-1-sa-slabeasca-sute-de-procese-invoca-un-risc-rar-de-pierdere-a-vederii-23814752", "title": "Cine deține puterea în lume și cum o folosește?", "publisher": "mediafax.ro", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-09-27T03:04:58.735395Z", "published_at": "2026-09-26T20:08:00Z"}, {"url": "https://spotmedia.ro/stiri/opinii-si-analize/cine-detine-puterea-in-lume-si-cum-o-foloseste", "title": "", "publisher": "spotmedia.ro", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-09-27T03:04:58.728751Z", "published_at": null}, {"url": "https://spotmedia.ro/stiri/politica/un-deputat-usr-a-depus-plangere-penala-pentru-tradare-impotriva-lui-grindeanu-simion-si-ivan-dupa-articolul-wsj", "title": "", "publisher": "spotmedia.ro", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-09-27T03:04:58.729863Z", "published_at": null}, {"url": "https://spotmedia.ro/stiri/sanatate/stim-ce-efecte-are-lipsa-miscarii-asupra-corpului-dar-ce-se-intampla-cu-mintea-cand-lasam-ai-sa-gandeasca-in-locul-nostru", "title": "", "publisher": "spotmedia.ro", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-09-27T03:04:58.730786Z", "published_at": null}, {"url": "https://spotmedia.ro/stiri/timp-liber/tot-mai-multe-femei-pleaca-singure-in-vacanta-nu-pentru-ca-n-au-cu-cine-ci-pentru-ca-vor-sa-faca-propria-alegere-ce-trebuie-sa-stii-inainte-sa-faci-un-astfel-de-pas", "title": "", "publisher": "spotmedia.ro", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-09-27T03:04:58.731270Z", "published_at": null}]}, "wireva:publication": {"name": "Prisma Zilei", "domain": "prismazilei.mib.news", "country": "RO", "url": "https://prismazilei.mib.news/externe/sute-de-procese-invoca-un-risc-rar-de-pierdere-a-vederii-la-medicamentele-glp-1-pentru-slabit/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/39f70f38-fdf5-48f6-a5e1-423f6b76c390", "html": "https://wireva.mib.news/item/39f70f38-fdf5-48f6-a5e1-423f6b76c390/sute-de-procese-invoca-un-risc-rar-de-pierdere-a-vederii-la-medicamentele-glp-1-pentru-slabit/", "story": "https://wireva.mib.news/story/sute-de-procese-invoca-un-risc-rar-de-pierdere-a-vederii-la-medicamentele-glp-1-pentru-slabit-20260927/"}, "wireva:metrics": {"word_count": 651, "char_count": 4541, "reading_time_seconds": 324}}}}, "extra": {"wireva:languages": ["ro"], "wireva:status": "developing", "wireva:item_count": 1}}